Pharma & Healthcare
Global Recombinant Bone Morphogenetic Protein-2 Market Research Report 2026
- May 01, 26
- ID: 749316
- Pages: 92
- Figures: 99
- Views: 11
This report delivers a comprehensive overview of the global Recombinant Bone Morphogenetic Protein-2 market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Recombinant Bone Morphogenetic Protein-2. The Recombinant Bone Morphogenetic Protein-2 market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Recombinant Bone Morphogenetic Protein-2 market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Recombinant Bone Morphogenetic Protein-2 manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Medtronic
Jiuyuan Gene Engineering
Cellumed
Segment by Type
Sponge Carrier
Hydroxyapatite Carrier
by Application
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Recombinant Bone Morphogenetic Protein-2 manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Recombinant Bone Morphogenetic Protein-2 sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Recombinant Bone Morphogenetic Protein-2 market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Recombinant Bone Morphogenetic Protein-2 manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Medtronic
Jiuyuan Gene Engineering
Cellumed
Segment by Type
Sponge Carrier
Hydroxyapatite Carrier
by Application
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Recombinant Bone Morphogenetic Protein-2 manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Recombinant Bone Morphogenetic Protein-2 sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Recombinant Bone Morphogenetic Protein-2 Market Overview
1.1 Product Definition
1.2 Recombinant Bone Morphogenetic Protein-2 by Type
1.2.1 Global Recombinant Bone Morphogenetic Protein-2 Market Value by Type: 2025 vs 2032
1.2.2 Sponge Carrier
1.2.3 Hydroxyapatite Carrier
1.3 Recombinant Bone Morphogenetic Protein-2 by Application
1.3.1 Global Recombinant Bone Morphogenetic Protein-2 Market Value by Application: 2025 vs 2032
1.3.2 Spinal Fusion
1.3.3 Trauma Surgery
1.3.4 Oral Maxillofacial Surgery
1.3.5 Reconstructive
1.4 Global Recombinant Bone Morphogenetic Protein-2 Market Size Estimates and Forecasts
1.4.1 Global Recombinant Bone Morphogenetic Protein-2 Revenue 2021–2032
1.4.2 Global Recombinant Bone Morphogenetic Protein-2 Sales 2021–2032
1.4.3 Global Recombinant Bone Morphogenetic Protein-2 Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Recombinant Bone Morphogenetic Protein-2 Market Competition by Manufacturers
2.1 Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Manufacturers (2021–2026)
2.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Recombinant Bone Morphogenetic Protein-2 Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Recombinant Bone Morphogenetic Protein-2, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Recombinant Bone Morphogenetic Protein-2, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Recombinant Bone Morphogenetic Protein-2, Product Types and Applications
2.7 Global Key Manufacturers of Recombinant Bone Morphogenetic Protein-2, Date of Entry into the Industry
2.8 Global Recombinant Bone Morphogenetic Protein-2 Market Competitive Situation and Trends
2.8.1 Global Recombinant Bone Morphogenetic Protein-2 Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Recombinant Bone Morphogenetic Protein-2 Players Market Share by Revenue
2.8.3 Global Recombinant Bone Morphogenetic Protein-2 Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Bone Morphogenetic Protein-2 Market Scenario by Region
3.1 Global Recombinant Bone Morphogenetic Protein-2 Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Recombinant Bone Morphogenetic Protein-2 Sales by Region: 2021–2032
3.2.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Region: 2021–2026
3.2.2 Global Recombinant Bone Morphogenetic Protein-2 Sales by Region: 2027–2032
3.3 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Region: 2021–2032
3.3.1 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Region: 2021–2026
3.3.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Region: 2027–2032
3.4 North America Recombinant Bone Morphogenetic Protein-2 Market Facts & Figures by Country
3.4.1 North America Recombinant Bone Morphogenetic Protein-2 Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Recombinant Bone Morphogenetic Protein-2 Sales by Country (2021–2032)
3.4.3 North America Recombinant Bone Morphogenetic Protein-2 Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Bone Morphogenetic Protein-2 Market Facts & Figures by Country
3.5.1 Europe Recombinant Bone Morphogenetic Protein-2 Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Recombinant Bone Morphogenetic Protein-2 Sales by Country (2021–2032)
3.5.3 Europe Recombinant Bone Morphogenetic Protein-2 Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Bone Morphogenetic Protein-2 Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Bone Morphogenetic Protein-2 Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Recombinant Bone Morphogenetic Protein-2 Sales by Region (2021–2032)
3.6.3 Asia Pacific Recombinant Bone Morphogenetic Protein-2 Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Bone Morphogenetic Protein-2 Market Facts & Figures by Country
3.7.1 Latin America Recombinant Bone Morphogenetic Protein-2 Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Recombinant Bone Morphogenetic Protein-2 Sales by Country (2021–2032)
3.7.3 Latin America Recombinant Bone Morphogenetic Protein-2 Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Sales by Country (2021–2032)
3.8.3 Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Type (2021–2032)
4.1.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Type (2021–2026)
4.1.2 Global Recombinant Bone Morphogenetic Protein-2 Sales by Type (2027–2032)
4.1.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Type (2021–2032)
4.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Type (2021–2032)
4.2.1 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Type (2021–2026)
4.2.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Type (2027–2032)
4.2.3 Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Type (2021–2032)
4.3 Global Recombinant Bone Morphogenetic Protein-2 Price by Type (2021–2032)
5 Segment by Application
5.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Application (2021–2032)
5.1.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Application (2021–2026)
5.1.2 Global Recombinant Bone Morphogenetic Protein-2 Sales by Application (2027–2032)
5.1.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Application (2021–2032)
5.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Application (2021–2032)
5.2.1 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Application (2021–2026)
5.2.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Application (2027–2032)
5.2.3 Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Application (2021–2032)
5.3 Global Recombinant Bone Morphogenetic Protein-2 Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Recombinant Bone Morphogenetic Protein-2 Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Recombinant Bone Morphogenetic Protein-2 Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Jiuyuan Gene Engineering
6.2.1 Jiuyuan Gene Engineering Company Information
6.2.2 Jiuyuan Gene Engineering Description and Business Overview
6.2.3 Jiuyuan Gene Engineering Recombinant Bone Morphogenetic Protein-2 Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Jiuyuan Gene Engineering Recombinant Bone Morphogenetic Protein-2 Product Portfolio
6.2.5 Jiuyuan Gene Engineering Recent Developments/Updates
6.3 Cellumed
6.3.1 Cellumed Company Information
6.3.2 Cellumed Description and Business Overview
6.3.3 Cellumed Recombinant Bone Morphogenetic Protein-2 Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Cellumed Recombinant Bone Morphogenetic Protein-2 Product Portfolio
6.3.5 Cellumed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Bone Morphogenetic Protein-2 Industry Chain Analysis
7.2 Recombinant Bone Morphogenetic Protein-2 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Bone Morphogenetic Protein-2 Production Mode & Process Analysis
7.4 Recombinant Bone Morphogenetic Protein-2 Sales and Marketing
7.4.1 Recombinant Bone Morphogenetic Protein-2 Sales Channels
7.4.2 Recombinant Bone Morphogenetic Protein-2 Distributors
7.5 Recombinant Bone Morphogenetic Protein-2 Customer Analysis
8 Recombinant Bone Morphogenetic Protein-2 Market Dynamics
8.1 Recombinant Bone Morphogenetic Protein-2 Industry Trends
8.2 Recombinant Bone Morphogenetic Protein-2 Market Drivers
8.3 Recombinant Bone Morphogenetic Protein-2 Market Challenges
8.4 Recombinant Bone Morphogenetic Protein-2 Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Recombinant Bone Morphogenetic Protein-2 by Type
1.2.1 Global Recombinant Bone Morphogenetic Protein-2 Market Value by Type: 2025 vs 2032
1.2.2 Sponge Carrier
1.2.3 Hydroxyapatite Carrier
1.3 Recombinant Bone Morphogenetic Protein-2 by Application
1.3.1 Global Recombinant Bone Morphogenetic Protein-2 Market Value by Application: 2025 vs 2032
1.3.2 Spinal Fusion
1.3.3 Trauma Surgery
1.3.4 Oral Maxillofacial Surgery
1.3.5 Reconstructive
1.4 Global Recombinant Bone Morphogenetic Protein-2 Market Size Estimates and Forecasts
1.4.1 Global Recombinant Bone Morphogenetic Protein-2 Revenue 2021–2032
1.4.2 Global Recombinant Bone Morphogenetic Protein-2 Sales 2021–2032
1.4.3 Global Recombinant Bone Morphogenetic Protein-2 Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Recombinant Bone Morphogenetic Protein-2 Market Competition by Manufacturers
2.1 Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Manufacturers (2021–2026)
2.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Recombinant Bone Morphogenetic Protein-2 Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Recombinant Bone Morphogenetic Protein-2, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Recombinant Bone Morphogenetic Protein-2, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Recombinant Bone Morphogenetic Protein-2, Product Types and Applications
2.7 Global Key Manufacturers of Recombinant Bone Morphogenetic Protein-2, Date of Entry into the Industry
2.8 Global Recombinant Bone Morphogenetic Protein-2 Market Competitive Situation and Trends
2.8.1 Global Recombinant Bone Morphogenetic Protein-2 Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Recombinant Bone Morphogenetic Protein-2 Players Market Share by Revenue
2.8.3 Global Recombinant Bone Morphogenetic Protein-2 Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Bone Morphogenetic Protein-2 Market Scenario by Region
3.1 Global Recombinant Bone Morphogenetic Protein-2 Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Recombinant Bone Morphogenetic Protein-2 Sales by Region: 2021–2032
3.2.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Region: 2021–2026
3.2.2 Global Recombinant Bone Morphogenetic Protein-2 Sales by Region: 2027–2032
3.3 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Region: 2021–2032
3.3.1 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Region: 2021–2026
3.3.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Region: 2027–2032
3.4 North America Recombinant Bone Morphogenetic Protein-2 Market Facts & Figures by Country
3.4.1 North America Recombinant Bone Morphogenetic Protein-2 Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Recombinant Bone Morphogenetic Protein-2 Sales by Country (2021–2032)
3.4.3 North America Recombinant Bone Morphogenetic Protein-2 Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Bone Morphogenetic Protein-2 Market Facts & Figures by Country
3.5.1 Europe Recombinant Bone Morphogenetic Protein-2 Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Recombinant Bone Morphogenetic Protein-2 Sales by Country (2021–2032)
3.5.3 Europe Recombinant Bone Morphogenetic Protein-2 Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Bone Morphogenetic Protein-2 Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Bone Morphogenetic Protein-2 Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Recombinant Bone Morphogenetic Protein-2 Sales by Region (2021–2032)
3.6.3 Asia Pacific Recombinant Bone Morphogenetic Protein-2 Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Bone Morphogenetic Protein-2 Market Facts & Figures by Country
3.7.1 Latin America Recombinant Bone Morphogenetic Protein-2 Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Recombinant Bone Morphogenetic Protein-2 Sales by Country (2021–2032)
3.7.3 Latin America Recombinant Bone Morphogenetic Protein-2 Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Sales by Country (2021–2032)
3.8.3 Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Type (2021–2032)
4.1.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Type (2021–2026)
4.1.2 Global Recombinant Bone Morphogenetic Protein-2 Sales by Type (2027–2032)
4.1.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Type (2021–2032)
4.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Type (2021–2032)
4.2.1 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Type (2021–2026)
4.2.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Type (2027–2032)
4.2.3 Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Type (2021–2032)
4.3 Global Recombinant Bone Morphogenetic Protein-2 Price by Type (2021–2032)
5 Segment by Application
5.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Application (2021–2032)
5.1.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Application (2021–2026)
5.1.2 Global Recombinant Bone Morphogenetic Protein-2 Sales by Application (2027–2032)
5.1.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Application (2021–2032)
5.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Application (2021–2032)
5.2.1 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Application (2021–2026)
5.2.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Application (2027–2032)
5.2.3 Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Application (2021–2032)
5.3 Global Recombinant Bone Morphogenetic Protein-2 Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Recombinant Bone Morphogenetic Protein-2 Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Recombinant Bone Morphogenetic Protein-2 Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Jiuyuan Gene Engineering
6.2.1 Jiuyuan Gene Engineering Company Information
6.2.2 Jiuyuan Gene Engineering Description and Business Overview
6.2.3 Jiuyuan Gene Engineering Recombinant Bone Morphogenetic Protein-2 Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Jiuyuan Gene Engineering Recombinant Bone Morphogenetic Protein-2 Product Portfolio
6.2.5 Jiuyuan Gene Engineering Recent Developments/Updates
6.3 Cellumed
6.3.1 Cellumed Company Information
6.3.2 Cellumed Description and Business Overview
6.3.3 Cellumed Recombinant Bone Morphogenetic Protein-2 Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Cellumed Recombinant Bone Morphogenetic Protein-2 Product Portfolio
6.3.5 Cellumed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Bone Morphogenetic Protein-2 Industry Chain Analysis
7.2 Recombinant Bone Morphogenetic Protein-2 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Bone Morphogenetic Protein-2 Production Mode & Process Analysis
7.4 Recombinant Bone Morphogenetic Protein-2 Sales and Marketing
7.4.1 Recombinant Bone Morphogenetic Protein-2 Sales Channels
7.4.2 Recombinant Bone Morphogenetic Protein-2 Distributors
7.5 Recombinant Bone Morphogenetic Protein-2 Customer Analysis
8 Recombinant Bone Morphogenetic Protein-2 Market Dynamics
8.1 Recombinant Bone Morphogenetic Protein-2 Industry Trends
8.2 Recombinant Bone Morphogenetic Protein-2 Market Drivers
8.3 Recombinant Bone Morphogenetic Protein-2 Market Challenges
8.4 Recombinant Bone Morphogenetic Protein-2 Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Recombinant Bone Morphogenetic Protein-2 Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Recombinant Bone Morphogenetic Protein-2 Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Recombinant Bone Morphogenetic Protein-2 Market Competitive Situation by Manufacturers in 2025
Table 4. Global Recombinant Bone Morphogenetic Protein-2 Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Recombinant Bone Morphogenetic Protein-2 Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Recombinant Bone Morphogenetic Protein-2 Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Recombinant Bone Morphogenetic Protein-2 Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Recombinant Bone Morphogenetic Protein-2, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Recombinant Bone Morphogenetic Protein-2, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Recombinant Bone Morphogenetic Protein-2, Product Types and Applications
Table 12. Global Key Manufacturers of Recombinant Bone Morphogenetic Protein-2, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Bone Morphogenetic Protein-2 Companies by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Bone Morphogenetic Protein-2 Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Bone Morphogenetic Protein-2 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Recombinant Bone Morphogenetic Protein-2 Sales by Region (Units), 2021–2026
Table 18. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Region (2021–2026)
Table 19. Global Recombinant Bone Morphogenetic Protein-2 Sales by Region (Units), 2027–2032
Table 20. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Region (2027–2032)
Table 21. Global Recombinant Bone Morphogenetic Protein-2 Revenue by Region (US$ Million), 2021–2026
Table 22. Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Region (2021–2026)
Table 23. Global Recombinant Bone Morphogenetic Protein-2 Revenue by Region (US$ Million), 2027–2032
Table 24. Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Region (2027–2032)
Table 25. North America Recombinant Bone Morphogenetic Protein-2 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2021–2026
Table 27. North America Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2027–2032
Table 28. North America Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2021–2026
Table 29. North America Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Recombinant Bone Morphogenetic Protein-2 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2021–2026
Table 32. Europe Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2027–2032
Table 33. Europe Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Recombinant Bone Morphogenetic Protein-2 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2021–2026
Table 42. Latin America Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2027–2032
Table 43. Latin America Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2027–2032
Table 50. Global Recombinant Bone Morphogenetic Protein-2 Sales (Units) by Type (2021–2026)
Table 51. Global Recombinant Bone Morphogenetic Protein-2 Sales (Units) by Type (2027–2032)
Table 52. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Type (2021–2026)
Table 53. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Type (2027–2032)
Table 54. Global Recombinant Bone Morphogenetic Protein-2 Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Recombinant Bone Morphogenetic Protein-2 Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Type (2021–2026)
Table 57. Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Type (2027–2032)
Table 58. Global Recombinant Bone Morphogenetic Protein-2 Price (US$/Unit) by Type (2021–2026)
Table 59. Global Recombinant Bone Morphogenetic Protein-2 Price (US$/Unit) by Type (2027–2032)
Table 60. Global Recombinant Bone Morphogenetic Protein-2 Sales (Units) by Application (2021–2026)
Table 61. Global Recombinant Bone Morphogenetic Protein-2 Sales (Units) by Application (2027–2032)
Table 62. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Application (2021–2026)
Table 63. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Application (2027–2032)
Table 64. Global Recombinant Bone Morphogenetic Protein-2 Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Recombinant Bone Morphogenetic Protein-2 Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Application (2021–2026)
Table 67. Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Application (2027–2032)
Table 68. Global Recombinant Bone Morphogenetic Protein-2 Price (US$/Unit) by Application (2021–2026)
Table 69. Global Recombinant Bone Morphogenetic Protein-2 Price (US$/Unit) by Application (2027–2032)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Recombinant Bone Morphogenetic Protein-2 Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Medtronic Recombinant Bone Morphogenetic Protein-2 Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Jiuyuan Gene Engineering Company Information
Table 76. Jiuyuan Gene Engineering Description and Business Overview
Table 77. Jiuyuan Gene Engineering Recombinant Bone Morphogenetic Protein-2 Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Jiuyuan Gene Engineering Recombinant Bone Morphogenetic Protein-2 Product
Table 79. Jiuyuan Gene Engineering Recent Developments/Updates
Table 80. Cellumed Company Information
Table 81. Cellumed Description and Business Overview
Table 82. Cellumed Recombinant Bone Morphogenetic Protein-2 Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Cellumed Recombinant Bone Morphogenetic Protein-2 Product
Table 84. Cellumed Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Recombinant Bone Morphogenetic Protein-2 Distributors List
Table 88. Recombinant Bone Morphogenetic Protein-2 Customers List
Table 89. Recombinant Bone Morphogenetic Protein-2 Market Trends
Table 90. Recombinant Bone Morphogenetic Protein-2 Market Drivers
Table 91. Recombinant Bone Morphogenetic Protein-2 Market Challenges
Table 92. Recombinant Bone Morphogenetic Protein-2 Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Bone Morphogenetic Protein-2
Figure 2. Global Recombinant Bone Morphogenetic Protein-2 Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Recombinant Bone Morphogenetic Protein-2 Market Share by Type: 2025 & 2032
Figure 4. Sponge Carrier Product Picture
Figure 5. Hydroxyapatite Carrier Product Picture
Figure 6. Global Recombinant Bone Morphogenetic Protein-2 Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Recombinant Bone Morphogenetic Protein-2 Market Share by Application: 2025 & 2032
Figure 8. Spinal Fusion
Figure 9. Trauma Surgery
Figure 10. Oral Maxillofacial Surgery
Figure 11. Reconstructive
Figure 12. Global Recombinant Bone Morphogenetic Protein-2 Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Recombinant Bone Morphogenetic Protein-2 Market Size (US$ Million), 2021–2032
Figure 14. Global Recombinant Bone Morphogenetic Protein-2 Sales (Units), 2021–2032
Figure 15. Global Recombinant Bone Morphogenetic Protein-2 Average Price (US$/Unit), 2021–2032
Figure 16. Recombinant Bone Morphogenetic Protein-2 Report Years Considered
Figure 17. Recombinant Bone Morphogenetic Protein-2 Sales Share by Manufacturers in 2025
Figure 18. Global Recombinant Bone Morphogenetic Protein-2 Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Recombinant Bone Morphogenetic Protein-2 Players: Market Share by Revenue in Recombinant Bone Morphogenetic Protein-2 in 2025
Figure 20. Recombinant Bone Morphogenetic Protein-2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Recombinant Bone Morphogenetic Protein-2 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Country (2021–2032)
Figure 23. North America Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Country (2021–2032)
Figure 24. United States Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Country (2021–2032)
Figure 27. Europe Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Country (2021–2032)
Figure 28. Germany Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Region (2021–2032)
Figure 35. China Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Country (2021–2032)
Figure 43. Latin America Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Recombinant Bone Morphogenetic Protein-2 by Type (2021–2032)
Figure 54. Global Revenue Market Share of Recombinant Bone Morphogenetic Protein-2 by Type (2021–2032)
Figure 55. Global Recombinant Bone Morphogenetic Protein-2 Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Recombinant Bone Morphogenetic Protein-2 by Application (2021–2032)
Figure 57. Global Revenue Market Share of Recombinant Bone Morphogenetic Protein-2 by Application (2021–2032)
Figure 58. Global Recombinant Bone Morphogenetic Protein-2 Price (US$/Unit) by Application (2021–2032)
Figure 59. Recombinant Bone Morphogenetic Protein-2 Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Recombinant Bone Morphogenetic Protein-2 Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Recombinant Bone Morphogenetic Protein-2 Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Recombinant Bone Morphogenetic Protein-2 Market Competitive Situation by Manufacturers in 2025
Table 4. Global Recombinant Bone Morphogenetic Protein-2 Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Recombinant Bone Morphogenetic Protein-2 Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Recombinant Bone Morphogenetic Protein-2 Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Recombinant Bone Morphogenetic Protein-2 Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Recombinant Bone Morphogenetic Protein-2, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Recombinant Bone Morphogenetic Protein-2, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Recombinant Bone Morphogenetic Protein-2, Product Types and Applications
Table 12. Global Key Manufacturers of Recombinant Bone Morphogenetic Protein-2, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Bone Morphogenetic Protein-2 Companies by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Bone Morphogenetic Protein-2 Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Bone Morphogenetic Protein-2 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Recombinant Bone Morphogenetic Protein-2 Sales by Region (Units), 2021–2026
Table 18. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Region (2021–2026)
Table 19. Global Recombinant Bone Morphogenetic Protein-2 Sales by Region (Units), 2027–2032
Table 20. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Region (2027–2032)
Table 21. Global Recombinant Bone Morphogenetic Protein-2 Revenue by Region (US$ Million), 2021–2026
Table 22. Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Region (2021–2026)
Table 23. Global Recombinant Bone Morphogenetic Protein-2 Revenue by Region (US$ Million), 2027–2032
Table 24. Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Region (2027–2032)
Table 25. North America Recombinant Bone Morphogenetic Protein-2 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2021–2026
Table 27. North America Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2027–2032
Table 28. North America Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2021–2026
Table 29. North America Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Recombinant Bone Morphogenetic Protein-2 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2021–2026
Table 32. Europe Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2027–2032
Table 33. Europe Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Recombinant Bone Morphogenetic Protein-2 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2021–2026
Table 42. Latin America Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2027–2032
Table 43. Latin America Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Revenue by Country (US$ Million), 2027–2032
Table 50. Global Recombinant Bone Morphogenetic Protein-2 Sales (Units) by Type (2021–2026)
Table 51. Global Recombinant Bone Morphogenetic Protein-2 Sales (Units) by Type (2027–2032)
Table 52. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Type (2021–2026)
Table 53. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Type (2027–2032)
Table 54. Global Recombinant Bone Morphogenetic Protein-2 Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Recombinant Bone Morphogenetic Protein-2 Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Type (2021–2026)
Table 57. Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Type (2027–2032)
Table 58. Global Recombinant Bone Morphogenetic Protein-2 Price (US$/Unit) by Type (2021–2026)
Table 59. Global Recombinant Bone Morphogenetic Protein-2 Price (US$/Unit) by Type (2027–2032)
Table 60. Global Recombinant Bone Morphogenetic Protein-2 Sales (Units) by Application (2021–2026)
Table 61. Global Recombinant Bone Morphogenetic Protein-2 Sales (Units) by Application (2027–2032)
Table 62. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Application (2021–2026)
Table 63. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Application (2027–2032)
Table 64. Global Recombinant Bone Morphogenetic Protein-2 Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Recombinant Bone Morphogenetic Protein-2 Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Application (2021–2026)
Table 67. Global Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Application (2027–2032)
Table 68. Global Recombinant Bone Morphogenetic Protein-2 Price (US$/Unit) by Application (2021–2026)
Table 69. Global Recombinant Bone Morphogenetic Protein-2 Price (US$/Unit) by Application (2027–2032)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Recombinant Bone Morphogenetic Protein-2 Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Medtronic Recombinant Bone Morphogenetic Protein-2 Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Jiuyuan Gene Engineering Company Information
Table 76. Jiuyuan Gene Engineering Description and Business Overview
Table 77. Jiuyuan Gene Engineering Recombinant Bone Morphogenetic Protein-2 Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Jiuyuan Gene Engineering Recombinant Bone Morphogenetic Protein-2 Product
Table 79. Jiuyuan Gene Engineering Recent Developments/Updates
Table 80. Cellumed Company Information
Table 81. Cellumed Description and Business Overview
Table 82. Cellumed Recombinant Bone Morphogenetic Protein-2 Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Cellumed Recombinant Bone Morphogenetic Protein-2 Product
Table 84. Cellumed Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Recombinant Bone Morphogenetic Protein-2 Distributors List
Table 88. Recombinant Bone Morphogenetic Protein-2 Customers List
Table 89. Recombinant Bone Morphogenetic Protein-2 Market Trends
Table 90. Recombinant Bone Morphogenetic Protein-2 Market Drivers
Table 91. Recombinant Bone Morphogenetic Protein-2 Market Challenges
Table 92. Recombinant Bone Morphogenetic Protein-2 Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Bone Morphogenetic Protein-2
Figure 2. Global Recombinant Bone Morphogenetic Protein-2 Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Recombinant Bone Morphogenetic Protein-2 Market Share by Type: 2025 & 2032
Figure 4. Sponge Carrier Product Picture
Figure 5. Hydroxyapatite Carrier Product Picture
Figure 6. Global Recombinant Bone Morphogenetic Protein-2 Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Recombinant Bone Morphogenetic Protein-2 Market Share by Application: 2025 & 2032
Figure 8. Spinal Fusion
Figure 9. Trauma Surgery
Figure 10. Oral Maxillofacial Surgery
Figure 11. Reconstructive
Figure 12. Global Recombinant Bone Morphogenetic Protein-2 Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Recombinant Bone Morphogenetic Protein-2 Market Size (US$ Million), 2021–2032
Figure 14. Global Recombinant Bone Morphogenetic Protein-2 Sales (Units), 2021–2032
Figure 15. Global Recombinant Bone Morphogenetic Protein-2 Average Price (US$/Unit), 2021–2032
Figure 16. Recombinant Bone Morphogenetic Protein-2 Report Years Considered
Figure 17. Recombinant Bone Morphogenetic Protein-2 Sales Share by Manufacturers in 2025
Figure 18. Global Recombinant Bone Morphogenetic Protein-2 Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Recombinant Bone Morphogenetic Protein-2 Players: Market Share by Revenue in Recombinant Bone Morphogenetic Protein-2 in 2025
Figure 20. Recombinant Bone Morphogenetic Protein-2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Recombinant Bone Morphogenetic Protein-2 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Country (2021–2032)
Figure 23. North America Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Country (2021–2032)
Figure 24. United States Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Country (2021–2032)
Figure 27. Europe Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Country (2021–2032)
Figure 28. Germany Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Region (2021–2032)
Figure 35. China Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Country (2021–2032)
Figure 43. Latin America Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Recombinant Bone Morphogenetic Protein-2 Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Recombinant Bone Morphogenetic Protein-2 Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Recombinant Bone Morphogenetic Protein-2 by Type (2021–2032)
Figure 54. Global Revenue Market Share of Recombinant Bone Morphogenetic Protein-2 by Type (2021–2032)
Figure 55. Global Recombinant Bone Morphogenetic Protein-2 Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Recombinant Bone Morphogenetic Protein-2 by Application (2021–2032)
Figure 57. Global Revenue Market Share of Recombinant Bone Morphogenetic Protein-2 by Application (2021–2032)
Figure 58. Global Recombinant Bone Morphogenetic Protein-2 Price (US$/Unit) by Application (2021–2032)
Figure 59. Recombinant Bone Morphogenetic Protein-2 Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232